King of Prussia, PA, United States of America

Jennifer Dally

This inventor holds 9 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Dally. Retrieved from https://idiyas.com/inventor/jennifer-dally

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 20(Granted Patents)

Company Filing History:

9 out of 95

Glaxosmithkline Intellectual Property (No.2) Limited

patents

Years Active: 2020-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12454571 - Biopharmaceutical compositions (2025-10-28),

2. 12187791 - Biopharmaceutical compositions (2025-01-07),

3. 12187790 - Biopharmaceutical compositions (2025-01-07),

4. 12187789 - Biopharmaceutical compositions (2025-01-07),

5. 11459384 - Biopharmaceutical compositions (2022-10-04),

6. 11299541 - Biopharmaceutical compositions (2022-04-12),

7. 11286298 - Biopharmaceutical compositions (2022-03-29),

8. 11274148 - Biopharmaceutical compositions (2022-03-15),

9. 10870695 - Biopharmaceutical compositions comprising interleukin-5 antibody (2020-12-22),

Title: The Innovative Journey of Inventor Jennifer Dally

Introduction

Jennifer Dally is a distinguished inventor based in King of Prussia, Pennsylvania, known for her significant contributions to the field of biopharmaceuticals. With a remarkable portfolio of eight patents, Dally is at the forefront of developing innovative solutions to complex health challenges.

Latest Patents

Among her latest creations are biopharmaceutical compositions aimed at treating interleukin 5 (IL-5) mediated diseases. These patents detail the innovative methods and compositions developed to address these critical medical conditions, demonstrating her commitment to advancing healthcare through innovation.

Career Highlights

Currently, Jennifer Dally is dedicated to her role at GlaxoSmithKline Intellectual Property (No.2) Limited. Her work in this esteemed organization highlights her expertise and dedication to the field, as she collaborates with talented professionals to drive research forward and push the boundaries of what is possible in biopharmaceutical development.

Collaborations

Throughout her career, Dally has had the privilege of collaborating with notable colleagues such as Myrna A. Monck and Narendra B. Bam. These partnerships not only enrich her work but also contribute to a collective advancement in their field, as they share knowledge and insights to foster innovation.

Conclusion

Jennifer Dally exemplifies the spirit of innovation and dedication to improving healthcare through her impactful inventions. With a strong foundation in biopharmaceutical research, her work continues to pave the way for new treatments that can change lives, underlining the importance of inventors in the advancement of medicine.

Profile summary based on public USPTO records.